Funds › Privium Fund Management B.V.
Privium Fund Management B.V.
13F for Q3 2026, filed Nov 3, 2026. 58 positions worth $515.5M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Latest report
Q3 2026
filed Nov 3, 2026
Reported value
$515.5M
−$28.7M (5.3%) vs Q2 2026
Positions
58
61 in Q2 2026
Top 10 share
66.5%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Privium Fund Management B.V. in the latest 13F quarter?
Using 13F.ai, how has Privium Fund Management B.V.'s portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Privium Fund Management B.V.'s top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | TSLA Tesla, Inc. | 225,000 | $79.8M | 15.5% | -1.3% | 13F ↗ |
| 2 | SHOP Shopify Inc. | 305,000 | $45.2M | 8.8% | -17.6% | 13F ↗ |
| 3 | AMD Advanced Micro Devices, Inc. | 62,000 | $37.9M | 7.4% | Unchanged | 13F ↗ |
| 4 | SPCX Space Exploration Technologies Corp. | 250,000 | $37.7M | 7.3% | +525% | 13F ↗ |
| 5 | PLTR Palantir Technologies Inc. | 200,000 | $37.4M | 7.3% | Unchanged | 13F ↗ |
| 6 | AMZN Amazon.com, Inc. | 140,000 | $34.9M | 6.8% | Unchanged | 13F ↗ |
| 7 | CBRS Cerebras Systems Inc. | 111,000 | $19.7M | 3.8% | +83.5% | 13F ↗ |
| 8 | NVDA NVIDIA Corporation | 81,000 | $18.5M | 3.6% | Unchanged | 13F ↗ |
| 9 | SPOT Spotify Technology S.A. | 33,000 | $16.1M | 3.1% | -40.0% | 13F ↗ |
| 10 | IONS Ionis Pharmaceuticals, Inc. | 349,003 | $15.6M | 3.0% | +9.1% | 13F ↗ |
| 11 | IREN IREN Limited | 370,150 | $15.1M | 2.9% | +8.8% | 13F ↗ |
| 12 | ARWR Arrowhead Pharmaceuticals, Inc. | 215,818 | $14.1M | 2.7% | -7.9% | 13F ↗ |
| 13 | LMND Lemonade, Inc. | 270,259 | $12.2M | 2.4% | Unchanged | 13F ↗ |
| 14 | OPEN Opendoor Technologies Inc | 5.14M | $12.2M | 2.4% | +30.4% | 13F ↗ |
| 15 | BIIB Biogen Inc. | 48,400 | $10.9M | 2.1% | Unchanged | 13F ↗ |
| 16 | NBIS Nebius Group N.V. | 40,000 | $9.4M | 1.8% | New | 13F ↗ |
| 17 | PRQR ProQR Therapeutics N.V. · Shs Euro | 5.47M | $9.1M | 1.8% | -1.0% | 13F ↗ |
| 18 | ARQT Arcutis Biotherapeutics, Inc. | 333,193 | $8.8M | 1.7% | -16.6% | 13F ↗ |
| 19 | AXSM Axsome Therapeutics, Inc. | 42,944 | $7.9M | 1.5% | +7.5% | 13F ↗ |
| 20 | BBIO BridgeBio Pharma, Inc. | 89,151 | $5.9M | 1.1% | New | 13F ↗ |
| 21 | QURE uniQure N.V. | 216,197 | $5.2M | 1.0% | -34.2% | 13F ↗ |
| 22 | ALNY Alnylam Pharmaceuticals, Inc. | 20,607 | $5.1M | 1.0% | +81.2% | 13F ↗ |
| 23 | DNLI Denali Therapeutics Inc. | 229,857 | $4.8M | 0.9% | Unchanged | 13F ↗ |
| 24 | BMRN BioMarin Pharmaceutical Inc. | 75,000 | $4.5M | 0.9% | Unchanged | 13F ↗ |
| 25 | URGN UroGen Pharma Ltd. | 107,915 | $4.4M | 0.9% | -48.6% | 13F ↗ |
| 26 | NBIX Neurocrine Biosciences, Inc. | 26,200 | $3.7M | 0.7% | New | 13F ↗ |
| 27 | RARE Ultragenyx Pharmaceutical Inc. | 233,037 | $3.5M | 0.7% | -31.2% | 13F ↗ |
| 28 | KRYS Krystal Biotech, Inc. | 9,970 | $3.3M | 0.6% | -10.7% | 13F ↗ |
| 29 | BNTX BioNTech SE · ADR | 32,100 | $3.2M | 0.6% | +6.6% | 13F ↗ |
| 30 | SRPT Sarepta Therapeutics, Inc. | 166,605 | $3.0M | 0.6% | +22.1% | 13F ↗ |
| 31 | ABEV Ambev S.A. · ADR | 989,723 | $2.9M | 0.6% | +23.4% | 13F ↗ |
| 32 | CRSP CRISPR Therapeutics AG · Namen Akt | 48,974 | $2.7M | 0.5% | +8.9% | 13F ↗ |
| 33 | MGTX MeiraGTx Holdings plc | 208,512 | $2.3M | 0.4% | +6.3% | 13F ↗ |
| 34 | BEAM Beam Therapeutics Inc. | 91,282 | $2.2M | 0.4% | +29.9% | 13F ↗ |
| 35 | ZTS Zoetis Inc. | 23,643 | $1.7M | 0.3% | +36.5% | 13F ↗ |
| 36 | BTG B2Gold Corp | 265,505 | $1.4M | 0.3% | +36.1% | 13F ↗ |
| 37 | FDMT 4D Molecular Therapeutics, Inc. | 90,110 | $1.3M | 0.3% | Unchanged | 13F ↗ |
| 38 | TSHA Taysha Gene Therapies, Inc. | 232,900 | $1.1M | 0.2% | +17.1% | 13F ↗ |
| 39 | RNAC Cartesian Therapeutics, Inc. | 155,000 | $1.1M | 0.2% | +2.2% | 13F ↗ |
| 40 | FATE Fate Therapeutics, Inc. | 414,311 | $981.9K | 0.2% | Unchanged | 13F ↗ |
| 41 | AUTL Autolus Therapeutics plc | 469,490 | $910.8K | 0.2% | +29.2% | 13F ↗ |
| 42 | RIG Transocean Ltd · Common Stocks | 155,699 | $815.9K | 0.2% | +6.9% | 13F ↗ |
| 43 | MOH Molina Healthcare Inc | 4,064 | $768.5K | 0.1% | +36.4% | 13F ↗ |
| 44 | LULU lululemon athletica inc. | 7,023 | $675.5K | 0.1% | +38.7% | 13F ↗ |
| 45 | RCKT Rocket Pharmaceuticals, Inc. | 244,146 | $642.1K | 0.1% | Unchanged | 13F ↗ |
| 46 | NOV NOV Inc. | 34,050 | $637.8K | 0.1% | -19.0% | 13F ↗ |
| 47 | LXEO Lexeo Therapeutics, Inc. | 155,000 | $523.9K | 0.1% | Unchanged | 13F ↗ |
| 48 | SD SandRidge Energy, Inc. | 38,792 | $523.3K | 0.1% | Unchanged | 13F ↗ |
| 49 | NU Nu Holdings Ltd. | 38,168 | $483.2K | 0.1% | -13.3% | 13F ↗ |
| 50 | SA Seabridge Gold, Inc. | 14,172 | $401.6K | 0.1% | -14.2% | 13F ↗ |
Showing the top 50 of 58 positions. Premium lists every position, plus puts and calls.
Changes since Q2 2026
9 new, 21 added to, 13 trimmed, 12 exited, 15 unchanged. By estimated dollars.
New positions (9)
| NBIS Nebius Group N.V. | 40,000 | New | $9.4M |
| BBIO BridgeBio Pharma, Inc. | 89,151 | New | $5.9M |
| NBIX Neurocrine Biosciences, Inc. | 26,200 | New | $3.7M |
| Sprott Fds Tr Urani Miner Etf | 8,178 | New | $388.1K |
| RRC Range Resources Corporation | 7,147 | New | $264.7K |
| EXE Expand Energy Corporation | 3,046 | New | $256.1K |
| EQT EQT Corporation | 5,266 | New | $255.7K |
| PFE Pfizer, Inc. | 7,406 | New | $211.2K |
| Rbb Fund Trust Tweedy Browne | 13,250 | New | $203.0K |
Added to (21)
| SPCX Space Exploration Technologies Corp. | 250,000 | +525% | $31.7M |
| CBRS Cerebras Systems Inc. | 111,000 | +83.5% | $9.0M |
| OPEN Opendoor Technologies Inc | 5.14M | +30.4% | $2.8M |
| ALNY Alnylam Pharmaceuticals, Inc. | 20,607 | +81.2% | $2.3M |
| IONS Ionis Pharmaceuticals, Inc. | 349,003 | +9.1% | $1.3M |
| IREN IREN Limited | 370,150 | +8.8% | $1.2M |
| AXSM Axsome Therapeutics, Inc. | 42,944 | +7.5% | $553.2K |
| SRPT Sarepta Therapeutics, Inc. | 166,605 | +22.1% | $548.5K |
| ABEV Ambev S.A. · ADR | 989,723 | +23.4% | $547.7K |
| BEAM Beam Therapeutics Inc. | 91,282 | +29.9% | $513.5K |
Trimmed (13)
| SPOT Spotify Technology S.A. | 33,000 | -40.0% | -$10.7M |
| SHOP Shopify Inc. | 305,000 | -17.6% | -$9.6M |
| URGN UroGen Pharma Ltd. | 107,915 | -48.6% | -$4.1M |
| QURE uniQure N.V. | 216,197 | -34.2% | -$2.7M |
| ARQT Arcutis Biotherapeutics, Inc. | 333,193 | -16.6% | -$1.7M |
| RARE Ultragenyx Pharmaceutical Inc. | 233,037 | -31.2% | -$1.6M |
| ARWR Arrowhead Pharmaceuticals, Inc. | 215,818 | -7.9% | -$1.2M |
| TSLA Tesla, Inc. | 225,000 | -1.3% | -$1.1M |
| KRYS Krystal Biotech, Inc. | 9,970 | -10.7% | -$399.1K |
| NOV NOV Inc. | 34,050 | -19.0% | -$149.4K |
Exited (12)
| ASTS AST SpaceMobile, Inc. | 145,000 | Exited | -$12.9M |
| VRTX Vertex Pharmaceuticals Incorporated | 9,400 | Exited | -$4.7M |
| VRDN Viridian Therapeutics, Inc. | 173,516 | Exited | -$3.2M |
| HIMS Hims & Hers Health, Inc. | 80,000 | Exited | -$2.8M |
| ZLAB Zai Lab Limited · ADR | 122,189 | Exited | -$2.3M |
| MRNA Moderna, Inc. | 29,994 | Exited | -$2.1M |
| MICC The Magnum Ice Cream Company N.V. | 98,221 | Exited | -$1.5M |
| Wave Life Sciences Ltd | 241,010 | Exited | -$1.4M |
| LEGN Legend Biotech Corporation · ADR | 35,400 | Exited | -$1.0M |
| TTE TotalEnergies SE · Act | 10,723 | Exited | -$729.5K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Any two quarters side by side. Part of Premium.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 3, 2026 | 13F-HR | 58 | $515.5M | Current | SEC ↗ |
| Q2 2026 | Aug 7, 2026 | 13F-HR | 61 | $544.2M | Current | SEC ↗ |
| Q1 2026 | May 5, 2026 | 13F-HR | 60 | $480.3M | Current | SEC ↗ |
| Q4 2025 | Feb 3, 2026 | 13F-HR | 57 | $543.1M | Current | SEC ↗ |
| Q3 2025 | Nov 4, 2025 | 13F-HR | 59 | $556.3M | Current | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | 13F-HR | 55 | $463.5M | Current | SEC ↗ |
| Q1 2025 | May 9, 2025 | 13F-HR | 56 | $383.6M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer